Access disease-level, longitudinal, oncology patient data to inform life science research, development, and commercial strategies with Vantage.
From R&D to post marketing and HEOR, Vantage helps oncology biopharma teams identify opportunities and create enterprise level strategies for specific cancer diagnoses.
Conduct Phase IV and HEOR studies and optimize commercial strategy.
COTA’s database of patients includes longitudinal treatment and outcomes data for oncology patients including:
Explore our collection of clinical research, recent press, podcasts, and more.
Four Ways Pharmaceutical Companies Are De-Risking R&D with Real-World Data Pharmaceutical research and development is inherently complex and high-risk. Sponsors...
Cancer affects everyone, including adolescents and young adults who are at increasing risk of developing certain types of disease. It’s...
Cancer is a disease that respects no borders: it affects everyone around the world, no matter where they live. The...
Discover the power of real-world cancer data for your life science organization.
